Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan's Ministry Holds Strategy Meeting On Hepatitis Treatment

This article was originally published in PharmAsia News

Executive Summary

To promote the development of new drugs and treatment for viral hepatitis B and hepatitis C, the Ministry of Health, Labor and Welfare established a Hepatitis Treatment Strategy Council and will hold the first meeting May 27. The meeting will discuss such topics as reducing the side effects of current treatments, treatments for relapsing patients and the development of the next generation of antiviral and cirrhosis drugs. The meeting will also discuss measures such as increased budget funding and more basic research to encourage development of new therapeutic drugs. (Click here for more - Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068576

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel